Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
41.46
-0.23 (-0.55%)
At close: Jun 26, 2026, 4:00 PM EDT
40.75
-0.71 (-1.72%)
After-hours: Jun 26, 2026, 7:20 PM EDT
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $4.46 billion as of June 26, 2026. Its market cap has increased by 169.23% in one year.
Market Cap
4.46B
Enterprise Value
3.97B
1-Year Change
169.23%
Ranking
Category
Stock Price
$41.46
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $4.46B, an increase of 486.12%. That is a compound annual growth rate of 40.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 4.46B | 69.80% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 4.93B |
| Celcuity | 4.74B |
| Definium Therapeutics | 4.74B |
| Erasca | 4.72B |
| ACADIA Pharmaceuticals | 4.42B |
| Tango Therapeutics | 4.40B |
| Viking Therapeutics | 4.39B |
| Relay Therapeutics | 3.98B |